Discover
ELV
Elevance Health, Inc.
416.19
120 x undefined
40 x undefined
bid
ask
+
29.46
7.62%
80 @ 05:26 AM
417.80 +1.61 (0.39%)
| Ytd | 18.72% | |
| 1y | 5.16% |
389.56
day range
416.23
273.71
52 week range
426.98
| Open | 389.90 | Prev Close | 386.73 | Low | 389.56 | High | 416.23 | Mkt Cap | 90.38B |
| Vol | 1.56M | Avg Vol | 1.74M | EPS | 23.60 | P/E | 17.64 | Forward P/E | 13.24 |
| Beta | 0.68 | Short Ratio | 3.75 | Inst. Own | 93.91% | Dividend | 6.88 | Div Yield | 1.77 |
| Ex Div Date | 06-10 | Earning | 07-16 | 50-d Avg | 387.00 | 200-d Avg | 344.43 | 1yr Est | 418.67 |
| Income Statement | |||
| Total Revenue | 50.18B | ||
| Revenues (USD) | 50.18B | ||
| Cost of Revenue | 41.08B | ||
| Gross Profit | 9.10B | ||
| Operating Expenses | 6.44B | ||
| Selling, General and Administrative Expense | 6.33B | ||
| Operating Income | 2.66B | ||
| Interest Expense | 357.00M | ||
| Income Tax Expense | 544.00M | ||
| Net Income | 1.76B | ||
| Net Income Common Stock | 1.76B | ||
| Net Income Common Stock (USD) | 1.76B | ||
| Consolidated Income | 1.76B | ||
| Net Income to Non-Controlling Interests | -4.00M | ||
| Earnings per Basic Share | 8.03 | ||
| Earnings per Basic Share (USD) | 8.03 | ||
| Earnings per Diluted Share | 8.00 | ||
| Dividends per Basic Common Share | 1.72 | ||
| Earning Before Interest & Taxes (EBIT) | 2.67B | ||
| Earning Before Interest & Taxes (USD) | 2.67B | ||
| Weighted Average Shares | 220.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.66B | ||
| Cash and Equivalents (USD) | 9.66B | ||
| Investments | 39.54B | ||
| Investments Current | 27.42B | ||
| Investments Non-Current | 12.12B | ||
| Trade and Non-Trade Receivables | 22.79B | ||
| Current Assets | 67.03B | ||
| Property, Plant & Equipment Net | 4.66B | ||
| Total Assets | 125.83B | ||
| Debt Current | 1.07B | ||
| Total Debt | 31.84B | ||
| Current Liabilities | 45.31B | ||
| Debt Non-Current | 30.77B | ||
| Total Liabilities | 81.79B | ||
| Accumulated Retained Earnings (Deficit) | 35.80B | ||
| Accumulated Other Comprehensive Income | -741.00M | ||
| Shareholders Equity | 43.90B | ||
| Shareholders Equity (USD) | 43.90B | ||
| Assets Non-Current | 58.80B | ||
| Total Debt (USD) | 31.84B | ||
| Deferred Revenue | 1.76B | ||
| Goodwill and Intangible Assets | 39.43B | ||
| Liabilities Non-Current | 36.48B | ||
| Trade and Non-Trade Payables | 24.63B | ||
| Tax Liabilities | 1.79B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 354.00M | ||
| Net Cash Flow from Financing | -2.51B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 166.00M | ||
| Capital Expenditure | -235.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 5.00M | ||
| Issuance (Purchase) of Equity Shares | -1.09B | ||
| Issuance (Repayment) of Debt Securities | -1.33B | ||
| Payment of Dividends & Other Cash Distributions | -376.00M | ||
| Net Cash Flow from Investing | -1.64B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.09B | ||
| Net Cash Flow from Operations | 4.33B | ||
| Effect of Exchange Rate Changes on Cash | -9.00M | ||
| Share Based Compensation | 55.00M | ||